Literature DB >> 28746819

Humanized Mouse Models for Human Immunodeficiency Virus Infection.

Matthew D Marsden1, Jerome A Zack1,2.   

Abstract

Human immunodeficiency virus (HIV) remains a significant source of morbidity and mortality worldwide. No effective vaccine is available to prevent HIV transmission, and although antiretroviral therapy can prevent disease progression, it does not cure HIV infection. Substantial effort is therefore currently directed toward basic research on HIV pathogenesis and persistence and developing methods to stop the spread of the HIV epidemic and cure those individuals already infected with HIV. Humanized mice are versatile tools for the study of HIV and its interaction with the human immune system. These models generally consist of immunodeficient mice transplanted with human cells or reconstituted with a near-complete human immune system. Here, we describe the major humanized mouse models currently in use, and some recent advances that have been made in HIV research/therapeutics using these models.

Entities:  

Keywords:  AIDS; BLT; HIV; humanized mice; model

Mesh:

Substances:

Year:  2017        PMID: 28746819      PMCID: PMC6542458          DOI: 10.1146/annurev-virology-101416-041703

Source DB:  PubMed          Journal:  Annu Rev Virol        ISSN: 2327-056X            Impact factor:   10.431


  123 in total

1.  Generation of HIV latency during thymopoiesis.

Authors:  D G Brooks; S G Kitchen; C M Kitchen; D D Scripture-Adams; J A Zack
Journal:  Nat Med       Date:  2001-04       Impact factor: 53.440

2.  Multiple blocks to human immunodeficiency virus type 1 replication in rodent cells.

Authors:  P D Bieniasz; B R Cullen
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Identification of T cell-signaling pathways that stimulate latent HIV in primary cells.

Authors:  David G Brooks; Philip A Arlen; Lianying Gao; Christina M R Kitchen; Jerome A Zack
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-20       Impact factor: 11.205

4.  Predominant autoantibody production by early human B cell precursors.

Authors:  Hedda Wardemann; Sergey Yurasov; Anne Schaefer; James W Young; Eric Meffre; Michel C Nussenzweig
Journal:  Science       Date:  2003-08-14       Impact factor: 47.728

5.  Molecular characterization, reactivation, and depletion of latent HIV.

Authors:  David G Brooks; Dean H Hamer; Philip A Arlen; Lianying Gao; Greg Bristol; Christina M R Kitchen; Edward A Berger; Jerome A Zack
Journal:  Immunity       Date:  2003-09       Impact factor: 31.745

6.  Role of CD47 as a marker of self on red blood cells.

Authors:  P A Oldenborg; A Zheleznyak; Y F Fang; C F Lagenaur; H D Gresham; F P Lindberg
Journal:  Science       Date:  2000-06-16       Impact factor: 47.728

7.  IL-15 is an essential mediator of peripheral NK-cell homeostasis.

Authors:  Thomas Ranson; Christian A J Vosshenrich; Erwan Corcuff; Odile Richard; Werner Müller; James P Di Santo
Journal:  Blood       Date:  2003-02-13       Impact factor: 22.113

8.  Effects of prostratin on T-cell activation and human immunodeficiency virus latency.

Authors:  Yael D Korin; David G Brooks; Stephen Brown; Andrew Korotzer; Jerome A Zack
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

9.  CD47 (integrin-associated protein) engagement of dendritic cell and macrophage counterreceptors is required to prevent the clearance of donor lymphohematopoietic cells.

Authors:  B R Blazar; F P Lindberg; E Ingulli; A Panoskaltsis-Mortari; P A Oldenborg; K Iizuka; W M Yokoyama; P A Taylor
Journal:  J Exp Med       Date:  2001-08-20       Impact factor: 14.307

10.  Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice.

Authors:  M K Kennedy; M Glaccum; S N Brown; E A Butz; J L Viney; M Embers; N Matsuki; K Charrier; L Sedger; C R Willis; K Brasel; P J Morrissey; K Stocking; J C Schuh; S Joyce; J J Peschon
Journal:  J Exp Med       Date:  2000-03-06       Impact factor: 14.307

View more
  42 in total

1.  Modeling Unique Patients in Humanized Mice: Toward a Curative Strategy for HIV.

Authors:  Marcus Dorner; Ype P de Jong
Journal:  Mol Ther       Date:  2018-02-07       Impact factor: 11.454

Review 2.  The Promise of Long-Acting Antiretroviral Therapies: From Need to Manufacture.

Authors:  Howard E Gendelman; JoEllyn McMillan; Aditya N Bade; Benson Edagwa; Bhavesh D Kevadiya
Journal:  Trends Microbiol       Date:  2019-04-10       Impact factor: 17.079

3.  Essential Role of Human T Cell Leukemia Virus Type 1 orf-I in Lethal Proliferation of CD4+ Cells in Humanized Mice.

Authors:  Veronica Galli; Christopher C Nixon; Natasa Strbo; Maria Artesi; Maria F de Castro-Amarante; Katherine McKinnon; Dai Fujikawa; Maria Omsland; Robyn Washington-Parks; Laura Romero; Breanna Caruso; Keith Durkin; Sophia Brown; Baktiar Karim; Monica Vaccari; Steve Jacobson; Jerome A Zack; Anne Van den Broeke; Cynthia Pise-Masison; Genoveffa Franchini
Journal:  J Virol       Date:  2019-09-12       Impact factor: 5.103

4.  TLR3 agonist and CD40-targeting vaccination induces immune responses and reduces HIV-1 reservoirs.

Authors:  Liang Cheng; Qi Wang; Guangming Li; Riddhima Banga; Jianping Ma; Haisheng Yu; Fumihiko Yasui; Zheng Zhang; Giuseppe Pantaleo; Matthieu Perreau; Sandra Zurawski; Gerard Zurawski; Yves Levy; Lishan Su
Journal:  J Clin Invest       Date:  2018-08-27       Impact factor: 14.808

Review 5.  The use of humanized mice for studies of viral pathogenesis and immunity.

Authors:  Florian Douam; Alexander Ploss
Journal:  Curr Opin Virol       Date:  2018-03-28       Impact factor: 7.090

6.  HIV Replication and Latency in a Humanized NSG Mouse Model during Suppressive Oral Combinational Antiretroviral Therapy.

Authors:  Sangeetha Satheesan; Haitang Li; John C Burnett; Mayumi Takahashi; Shasha Li; Shiny Xiaqin Wu; Timothy W Synold; John J Rossi; Jiehua Zhou
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

7.  Lentiviral Vector-Based Dendritic Cell Vaccine Suppresses HIV Replication in Humanized Mice.

Authors:  Thomas D Norton; Anjie Zhen; Takuya Tada; Jennifer Kim; Scott Kitchen; Nathaniel R Landau
Journal:  Mol Ther       Date:  2019-03-15       Impact factor: 11.454

8.  Both HIV and Tat expression decrease prepulse inhibition with further impairment by methamphetamine.

Authors:  T Jordan Walter; Jared W Young; Morgane Milienne-Petiot; D S Deben; Robert K Heaton; Scott Letendre; David J Grelotti; William Perry; Igor Grant; Arpi Minassian
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2020-09-04       Impact factor: 5.067

9.  TLR9- and CD40-Targeting Vaccination Promotes Human B Cell Maturation and IgG Induction via pDC-Dependent Mechanisms in Humanized Mice.

Authors:  Liang Cheng; Guangming Li; Caroline Marnata Pellegry; Fumihiko Yasui; Feng Li; Sandra M Zurawski; Gerard Zurawski; Yves Levy; Jenny P-Y Ting; Lishan Su
Journal:  Front Immunol       Date:  2021-05-18       Impact factor: 7.561

Review 10.  Humanized Mice for Infectious and Neurodegenerative disorders.

Authors:  Prasanta K Dash; Santhi Gorantla; Larisa Poluektova; Mahmudul Hasan; Emiko Waight; Chen Zhang; Milica Markovic; Benson Edagwa; Jatin Machhi; Katherine E Olson; Xinglong Wang; R Lee Mosley; Bhavesh Kevadiya; Howard E Gendelman
Journal:  Retrovirology       Date:  2021-06-05       Impact factor: 3.768

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.